Barenholz Yechezkel Projects

Results Found (7)
Technology NameBriefcaseLead Researcher
At a Glance Ayana Pharma is uniquely positioned to expand the uses and efficacy of the lipid-based cytotoxic drug’s well-established clinical profile. Invented by Prof. Yechezkel Barenholtz from the Hebrew University who is also the co-founder ...
More
Barenholz Yechezkel
Category LifeSciences and BioTechnology    Keywords Therapeutic Agents, Liposomes, Biochemistry, Doxorubicin, Sulfate, Alkyl Sulfonate, DoxilTM  Application Current preclinical and clinical data indicate that there is negligible release of ...
More
Barenholz Yechezkel
Category Life Sciences and Bio Technology    Keywords Chemotherapy, Drug resistance * The project is conducted in collaboration with Memorial Sloan-Kettering Cancer Center. Application Cells with multidrug resistance (MDR) due to aberrant ...
More
Barenholz Yechezkel
Company Name LipoCure Year Company was founded 2009 Company Founders Prof. Yechezkel Barenholtz Current CEO Dr. Liana Patt, Ph. D., MBA About the Company LipoCure is developing a number of highly-potent therapeutics utilizing proprietary ...
More
Barenholz Yechezkel
  Categories Drug Allergy, Drug Delivery, Nano-pharmaceuticals Development Stage TRL4, Successfully tested in large animals Patent Status US and Europe patent Opportunity Intravenous injection of some liposomal drugs, diagnostic agents, ...
More
Barenholz Yechezkel
Keywords Drug Delivery, Formulation Current development stage TRL7, Prototype and proprietary list of approved drugs that benefit from liposomal formulationsApplication Most active pharmaceutical ingredients (APIs) are not suitable for ...
More
Goldblum Amiram
  The physical size of protein drugs and their susceptibility to degradation are key determinates that make them more dependent on drug delivery technologies. However formulating protein delivery systems so that they maintain their stability ...
More
Barenholz Yechezkel